Ningbo MedicalSystem Biotechnology Co Ltd (300439) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.017x

Based on the latest financial reports, Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥48.96 Million ≈ $7.16 Million USD) by net assets (CN¥2.95 Billion ≈ $431.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Ningbo MedicalSystem Biotechnology Co Lt defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Ningbo MedicalSystem Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Ningbo MedicalSystem Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ningbo MedicalSystem Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ningbo MedicalSystem Biotechnology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
HiVi Acoustics Technology Co Ltd SHE:002888	0.013x
Aneka Gas Industri Tbk PT JK:AGII	0.026x
Comtec Sys KO:031820	-0.007x
Shenzhen Xinhao Photoelectricity Technology Co. Ltd SHE:301051	N/A
Zhejiang Lianxiang Smart Home SHG:603272	0.001x
Grand Pacific Petrochemical Corp TW:1312	-0.035x
Shaanxi Xinghua Chemistry Co Ltd SHE:002109	-0.015x
Kolon Corp KO:002020	-0.014x

Annual Cash Flow Conversion Efficiency for Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 300439 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.93 Billion ≈ $429.26 Million	CN¥397.81 Million ≈ $58.21 Million	0.136x	-42.06%
2023-12-31	CN¥2.71 Billion ≈ $396.07 Million	CN¥633.53 Million ≈ $92.71 Million	0.234x	+4.43%
2022-12-31	CN¥2.52 Billion ≈ $368.67 Million	CN¥564.67 Million ≈ $82.63 Million	0.224x	+3.95%
2021-12-31	CN¥2.39 Billion ≈ $349.84 Million	CN¥515.48 Million ≈ $75.43 Million	0.216x	-60.12%
2020-12-31	CN¥1.69 Billion ≈ $246.86 Million	CN¥912.07 Million ≈ $133.47 Million	0.541x	+24.86%
2019-12-31	CN¥1.39 Billion ≈ $203.16 Million	CN¥601.17 Million ≈ $87.97 Million	0.433x	+134.69%
2018-12-31	CN¥2.27 Billion ≈ $332.15 Million	CN¥418.80 Million ≈ $61.28 Million	0.185x	+428.61%
2017-12-31	CN¥2.29 Billion ≈ $334.63 Million	CN¥-128.40 Million ≈ $-18.79 Million	-0.056x	-4283.55%
2016-12-31	CN¥1.83 Billion ≈ $267.53 Million	CN¥2.45 Million ≈ $359.05K	0.001x	-99.03%
2015-12-31	CN¥1.29 Billion ≈ $188.39 Million	CN¥177.55 Million ≈ $25.98 Million	0.138x	-50.86%
2014-12-31	CN¥415.13 Million ≈ $60.75 Million	CN¥116.51 Million ≈ $17.05 Million	0.281x	-13.52%
2013-12-31	CN¥308.32 Million ≈ $45.12 Million	CN¥100.06 Million ≈ $14.64 Million	0.325x	+40.55%
2012-12-31	CN¥202.58 Million ≈ $29.64 Million	CN¥46.78 Million ≈ $6.85 Million	0.231x	-48.63%
2011-12-31	CN¥110.84 Million ≈ $16.22 Million	CN¥49.82 Million ≈ $7.29 Million	0.450x	--

About Ningbo MedicalSystem Biotechnology Co Ltd

SHE:300439 China Diagnostics & Research

Market Cap

$470.71 Million

CN¥3.22 Billion CNY

Market Cap Rank

#12718 Global

#3762 in China

Share Price

CN¥8.37

Change (1 day)

-0.24%

52-Week Range

CN¥8.37 - CN¥11.87

All Time High

CN¥49.34